IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Cancer Clinical Trial Compensation: Undue or Long Overdue?

Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

Real-World Data Shows Less Benefit for Mesothelioma from Checkpoint Inhibitors Vs. Clinical Trials

Real-World Data Show That Survival Just as Good With Carboplatin Therapy as With Cisplatin Therapy in Malignant Pleural Mesothelioma 

Bronchoscopic Ablation: A Small Step for Heat Therapy, a Giant Leap for Lung Cancer

Transbronchial Microwave Ablation of Malignant Lung Nodules: Outcomes, Challenges, and Perspective

Lung Cancer Surgery in the COVID-19 Era: What Has Changed?

Sublobar Resections for Early Lung Cancer

Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer

Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study

Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?